Talkiatry Secures $210 Million Series D to Scale AI-Driven Psychiatry Platform

New updates have been reported about Talkiatry.

Talkiatry has raised $210 million in an oversubscribed Series D round to accelerate the expansion of its national, in-network psychiatry platform and deepen partnerships with U.S. health systems, payers, and employers. The round, led by Perceptive Advisors with participation from Sofina, Andreessen Horowitz, blisce/, Left Lane Capital, and a debt facility from Banc of California, lifts Talkiatry’s total capital raised to more than $400 million and is aimed at funding technology investment and broader coverage across the acuity spectrum.

Positioning itself as the largest private employer of psychiatrists in the country, Talkiatry now directly employs more than 800 full-time psychiatrists and has delivered 3 million patient visits, while contracting with over 100 insurers that collectively cover more than 170 million lives. Since launching its Mindshare Partner Program in late 2023, the company has signed more than one-third of the nation’s top 20 health systems and over 50 systems in total, signaling growing institutional reliance on its model for scalable, in-network psychiatric care.

The company reports industry-leading clinical outcomes and cost performance, with 87 percent of anxiety patients and 86 percent of depression patients experiencing symptom improvement after just two visits, and roughly two-thirds in each cohort no longer meeting criteria for clinically significant symptoms. Early dropout rates are up to 60 percent lower than industry benchmarks, a metric that can materially reduce downstream utilization of higher-cost care settings and support value-based payment arrangements with health plans and health systems.

Talkiatry’s operating model is built on a proprietary AI-enabled platform that automates back-office tasks, supports referral and intake workflows for health systems, engages patients between appointments, and underpins innovative contracting structures with payers. Management expects this technology infrastructure, combined with a physician-led clinical model, to sustain quality and consistency as the company moves into more complex care segments and scales nationally, effectively positioning Talkiatry as a central psychiatry partner of record for large institutions.

CEO and cofounder Robert Krayn said the new capital will fund expansion into higher-acuity services and deeper enterprise partnerships as demand for measurable psychiatric outcomes grows across the healthcare ecosystem. Investor Perceptive Advisors highlighted Talkiatry’s integrated platform and consistent results in outcomes, engagement, and patient experience as key reasons for backing what it sees as a next-generation standard for U.S. psychiatric care.

The company also emphasizes clinician and patient experience as part of its competitive moat, reporting that 90 percent of its psychiatrists would recommend Talkiatry as a place to practice and that clinicians experience 80 percent less burnout than industry norms. Patient-reported metrics include a net promoter score of 76 and therapeutic alliance ratings 22 percent above peers, with 92 percent of patients indicating a strong rapport with their clinicians, factors that support retention, adherence, and long-term revenue stability as Talkiatry continues to scale.